Our analysis of CCND1 mutations subsequently focused on two endometrial adenocarcinoma cohorts, since this cancer subtype was most frequently enriched for c-terminal cyclin D1 mutations (Fig 1C and 1D). The gene discussed is CCND1; the disease is endometrium adenocarcinoma.